P450 BM3 Enzyme Variants for Selective Olefin Cyclopropanation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for the selective direct functionalization of unactivated carbon-hydrogen (C—H) bonds and carbon-carbon (C═C) double bonds face challenges in achieving high yield, regioselectivity, and stereoselectivity, often requiring expensive and toxic transition metal complexes under harsh conditions.
Innovation Solution
The use of novel iron-heme-containing enzyme catalysts for catalyzing the conversion of olefins to cyclopropanation products, which involves combining an olefinic substrate with a diazo reagent and a heme enzyme in a reaction to produce cyclopropanation products with high regio- and stereoselectivity without the need for harsh conditions or toxic metals.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If metallocarbenoid intermediates are used for direct introduction of carbon-carbon centers into complex structures, then new asymmetric highly substituted carbon centers and cyclopropanes are created, but expensive and possibly toxic transition metal complexes are required and harsh reaction conditions including high temperature and organic solvents are needed
Solution Approach 1:
The patent replaces expensive transition metal complexes with biodegradable enzyme catalysts (P450 BM3 variants) that can be easily disposed of or degraded, eliminating the persistence and toxicity issues associated with metal complexes while maintaining catalytic functionality for cyclopropanation reactions
Solution Approach 2:
The patent fundamentally changes the reaction parameters by conducting cyclopropanation reactions under mild physiological conditions (aqueous buffers, room temperature, neutral pH) instead of harsh conditions (high temperature, organic solvents), thereby eliminating the harmful effects while preserving reaction efficiency and stereoselectivity
2Manufacturing precision
If metallocarbenoid intermediates are used for direct introduction of carbon-carbon centers, then new asymmetric highly substituted carbon centers are created, but high yield, regioselectivity, and stereoselectivity remains difficult to achieve
Solution Approach 1:
The patent introduces specific amino acid mutations at strategic positions in the P450 BM3 enzyme active site (e.g., F87V, L181A, I263A) to create localized structural features that precisely control substrate binding orientation and carbene transfer geometry, thereby achieving high regioselectivity and stereoselectivity without compromising reaction yield
Solution Approach 2:
The patent employs a systematic enzyme engineering approach where reaction outcomes are analyzed and fed back into the design of improved enzyme variants through rational mutagenesis and directed evolution, progressively optimizing the balance between yield and selectivity in cyclopropanation reactions
3Ease of manufacture
If current catalytic approaches are used for selective direct functionalization of C—H bonds and C═C bonds, then functionalization is achieved, but expensive transition metal complexes and harsh reaction conditions are required
Solution Approach 1:
The patent replaces the mechanical/chemical system of transition metal catalysis with a biological enzyme catalyst system (P450 BM3 variants), substituting metal-based catalytic mechanisms with protein-based catalysis that operates under milder, more environmentally friendly conditions while reducing costs through biocatalysis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of cyclopropanation products with high yield and selectivity, offering a more environmentally friendly and cost-effective method compared to existing technologies, while avoiding the use of toxic transition metal complexes and harsh reaction conditions.
Implementation Method 1
cytochrome P450 enzymes (e.g., P450 BM3 (CYP102A1)) and variants thereof were identified as having an unexpectedly improved ability to catalyze the formal transfer of carbene equivalents from diazo reagents to various olefinic substrates
Data Source
AI summary
The present invention provides methods for catalyzing the conversion of an olefin to any compound containing one or more cyclopropane functional groups using heme enzymes. In certain aspects, the present invention provides a method for producing a cyclopropanation product comprising providing an olefinic substrate, a diazo reagent, and a heme enzyme; and admixing the components in a reaction for a time sufficient to produce a cyclopropanation product. In other aspects, the present invention provides heme enzymes including variants and fragments thereof that are capable of carrying out in vivo and in vitro olefin cyclopropanation reactions. Expression vectors and host cells expressing the heme enzymes are also provided by the present invention.